As announced in our third-quarter presentation on November 27, 2024, and reaffirmed in our fourth-quarter presentation on February 12, 2025, Avance Gas has completed the sale of all its assets and has ...

Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding ...

Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding from National Health Service ...

Learn more about whether Amarin Corporation plc or Catalyst Pharmaceuticals, Inc. is a better investment based on AAII's A+ ...

We recently published a list of 11 Best Russell 2000 Stocks to Buy According to Wall Street Analysts. In this article, we are ...

Health Canada granted priority review to an application seeking approval of vamorolone, marketed in the U.S. as Agamree, for ...

Catalyst Pharmaceuticals (NasdaqCM:CPRX) saw a minor decline of 3% over the past month amidst a backdrop of broader market volatility triggered by new tariffs and economic uncertainties. Despite the ...